LORI TOVAR: Open Payments
NPI 1255199410 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,305 in 49 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $989 · 2025 $1,305
Food & beverage: $1,221Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $427 |
| ABBVIE INC. | 7 | $217 |
| ViiV Healthcare Company | 8 | $172 |
| Melinta Therapeutics, LLC | 7 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $124 |
| Madrigal Pharmaceuticals | 3 | $109 |
| Ipsen Biopharmaceuticals, Inc | 1 | $51 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Napo Pharmaceuticals Inc | 1 | $21 |
| Shionogi Inc | 1 | $15 |
Products named: TREMFYA, Rezzayo, CREON, CABENUVA, REZDIFFRA, ENTYVIO, IQIRVO, LINZESS.
Industry payments across AZ — which companies pay providers there.
